Global Coronary Stents Market Size, Share & Trends Analysis Report by Stent Type (Drug-Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent, Others), by Deployment (Self-expandable, Balloon-expandable), by End User (Hospitals & Ambulatory Surgical Centres, Specialty Clinics, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) | Forecast [2024-2032]

Global Coronary Stents Market size was valued at USD 10.10 Billion in 2023 and is poised to grow from USD 10.44 Billion in 2024 to USD 13.54 Billion by 2032, growing at a CAGR of 3.31 % in the forecast period (2024-2032).

A recent market research report added to the repository of Intellectual Market Insights Research is an in-depth analysis of the United State Coronary Stents Market. Based on historic growth analysis and current scenario of Coronary Stents marketplace, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in the report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of the global Coronary Stents market. This further helps users with their developmental strategy.

Coronary Stents Market Players Analysis:

• Abbott
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• MicroPort Scientific Corporation
• R. Bard, Inc.
• Cook Medical

 

Coronary Stents Market Segmentation Analysis:

The market scope is segmented because of by Stent Type, by Deployment, by End User.

• By Stent Type

Based on the Stent Type of the market is segmented into Drug-Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent, Others.

Drug-Eluting Stent (DES) segment dominated the global market of coronary stents among others. The drug eluting stent is in much preference due to their capacity of providing maximum inhibition to restenosis-the narrowing of the artery following the insertion of the stent. Such stents contain a drug on their outer cover which gets gradually released preventing an excess of tissue growth inside it. Tissue growth inside is a most common reason of re-narrowing after the stenting of bare metal stents. There has been a lot of demand for DES due to their superior clinical outcomes, mainly in terms of long-term efficacy and patient safety.

The supremacy of DES is given because these have a proven track record of treating coronary artery disease most effectively while minimizing complications. Since coronary artery disease remains the leading cause of death in the world, treatments that reduce follow-up procedures and enhance patient outcomes are crucial. DES have consistently shown less incidence of restenosis and thrombosis as compared to BMS, resulting in their overall acceptance.

• By Deployment

Based on the Deployment of the market is segmented into Self-expandable, Balloon-expandable.

The balloon-expandable stents have been the market leader in the global coronary stents market, primarily due to their wide usage in interventional cardiology and better performance in many clinical scenarios. The balloon-expandable stent is designed to be expanded by inflating a balloon catheter after the stent has been positioned at the site of blockage in the coronary artery. This mechanism ensures high precision deployment in addition to radially optimized strength, and is especially effective at treating coronary artery disease wherein successful treatment outcomes critically depend on accurate deployment.

They are preferred across a wide variety of clinical uses because of better flexibility and for the ability to adapt to anatomy in the case of the coronary artery, especially in smaller, tortuous structures. They typically are used within high-risk patient populations because this type of intervention offers consistent reliable expansion, a factor that further reduces the rates of restenosis and various complications. A proven clinical benefit combined with emerging technologies such as drug-eluting balloon-expandable stents keeps them at market leadership.

• Regional Snapshots

The developed healthcare structure of North America, high healthcare expenses, and wide facilities for contemporary medical technologies have positioned this region at the top of the global market for coronary stents. In general, there is a built-up health care system in the U.S., which covers most coronary stent procedures by Medicare and private health insurance programs. The high volume of interventions being performed in North America and the early adoption curve for new stent technologies, such as drug-eluting and bioresorbable stents, has contributed to this position. Indeed, several of the leading medical device manufacturers and research institutions continue to interact and innovate with new and improved stent technologies. This is further supplemented by the acknowledgement of cardiovascular disease and treatment options in this sector both by healthcare professionals and patients. The other market, most likely to gain speed rapidly is that of the coronary stent in the Asia-Pacific region.

Further factors driving it are lifestyle changes, among others such as poor diets, smoking, and sedentary behaviour, which have boosted the incidence rate of cardiovascular diseases and ageing population of countries like China and India. The rapid improvements in healthcare infrastructure and access to highly advanced medical treatments in emerging economies also contribute to market growth. Other major drivers of the region to grow at an accelerated pace include increased government spending on healthcare and an increasingly middle-class population with greater health care spending capacity. Asia-Pacific is also observing increased awareness of preventive cardiovascular care and access to minimally invasive procedures, thereby supporting the adoption of coronary stents.

Key Benefits for Coronary Stents Market Reports:

The analysis provides an exhaustive investigation of the global Post-Consumer Coronary Stents Market together with the future projections to assess the investment feasibility. Furthermore, the report includes both quantitative and qualitative analyses of the Post-Consumer Coronary Stents Market throughout the forecast period. The report also comprehends business opportunities and scope for expansion. Besides this, it provides insights into market threats or barriers and the impact of regulatory framework to give an executive-level blueprint the Post-Consumer Coronary Stents Market.

 

Get Full Report:  https://www.intellectualmarketinsights.com/report/coronary-stents-market-size/imi-000624

About Us:

IMIR® Market Research Pvt Ltd.

Intellectual Market Insights Research is a Global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

IMIR has the distinguished objective of providing optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for Global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn

Mr. Smit Patel

Phone: +1 814 487 8486

Email: Smit@intellectualmarketinsights.com

Corporate Sales: Sales@intellectualmarketinsights.com